Water

Water

SCHEMBL9040201

COC(=O)C(C)Oc1cccc2nc3c(c(N)c12)CCCC3.O

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO

The experimentally established mechanism targets of Water. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACHE known ✓ P22303 14/20 0.65
▸ GRIN2A known ✓ Q12879 8/20 0.53
▸ CACNB4 known ✓ O00305 2/20 0.44
▸ CACNA1A known ✓ O00555 2/20 0.44
▸ CACNA1G known ✓ O43497 2/20 0.44
▸ CACNG3 known ✓ O60359 2/20 0.44
▸ CACNA1F known ✓ O60840 2/20 0.44
▸ CACNA1H known ✓ O95180 2/20 0.44
▸ CACNB3 known ✓ P54284 2/20 0.44
▸ CACNA2D1 known ✓ P54289 2/20 0.44
▸ CACNG7 known ✓ P62955 2/20 0.44
▸ CACNA1B known ✓ Q00975 2/20 0.44
▸ CACNA1D known ✓ Q01668 2/20 0.44
▸ CACNB1 known ✓ Q02641 2/20 0.44
▸ CACNG1 known ✓ Q06432 2/20 0.44
▸ CACNB2 known ✓ Q08289 2/20 0.44
▸ CACNA1S known ✓ Q13698 2/20 0.44
▸ CACNA1C known ✓ Q13936 2/20 0.44
▸ CACNA1E known ✓ Q15878 2/20 0.44
▸ CACNA2D4 known ✓ Q7Z3S7 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9739247 0.99 ACHE (0.67) ACHEBCHEGRIN1GRIN2ACACNB4
Water SCHEMBL9830096 0.89 ACHE (0.65) ACHEBCHEGRIN1GRIN2ACACNB4
Water SCHEMBL9039788 0.87 ACHE (0.59) ACHEBCHEGRIN1GRIN2ACACNB4
SCHEMBL9738826 0.85 ACHE (0.60) ACHEBCHEGRIN1GRIN2ACACNB4
Water SCHEMBL9043013 0.81 ACHE (0.57) ACHEBCHEGRIN1GRIN2ACACNB4
SCHEMBL9738570 0.80 ACHE (0.58) ACHEBCHEGRIN1GRIN2ACACNB4
SCHEMBL9039832 0.80 ACHE (1.00) ACHEBCHEGRIN1GRIN2ACACNB4
SCHEMBL9870090 0.80 ACHE (0.61) ACHEBCHEGRIN1GRIN2ACACNB4
SCHEMBL9870494 0.79 ACHE (0.60) ACHEBCHEGRIN1GRIN2ACACNB4
SCHEMBL9042257 0.75 ACHE (0.64) ACHEBCHEGRIN1GRIN2ACACNB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0430114-B1 Hexahydro-1H-quino[4,3,2-ef][1,4]benzoxazepines and related compounds, a process and intermediates for their preparation and their use as medicaments HOECHST ROUSSEL PHARMA (US) 1996-02-07 — — EP disclosed
US-5112829-A Intermediates for Cognition Activators HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1992-05-12 — — US disclosed
EP-0430114-A2 Hexahydro-1H-quino[4,3,2-ef][1,4]benzoxazepines and related compounds, a process and intermediates for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1991-06-05 — — EP disclosed
US-4994452-A Memory disfunction HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1991-02-19 — — US disclosed
Send feedback